Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
Kourelis TV, Buadi FK, Kumar SK, et al.
Am J Hematol · 2016
Key Findings
- ●5-year PFS 58%, 5-year OS 78%
- ●30% experienced relapse/progression
- ●Median time to relapse/progression 42 months
- ●Complete hematologic response associated with PFS of 88%
Referenced in (1 disease)
Validation history
Full log →- passsource metadataJun 1, 2026, 04:40 PMby pubmed-api
Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).
tools: pubmed.esummary, crossref.works
ID: pmid-26669974DOI: 10.1038/leu.2015.344PMID: 26669974